Crestline Management, LP
- SEC CIK
- 0001536054
- Latest filing
- Aug 14, 2026
Holdings in Q4 2025
Holdings as of Dec 31, 2025, filed Feb 17, 2026. Long positions only; changes compare share counts with Q3 2025.
- Positions
- 3
- 0 vs. Q3 2025
- Portfolio value
- $53.3M
- −$4.76M (−8.2%) vs. Q3 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| DNLIDenali Therapeutics Inc. | COM | 2,810,732 | $46.4M | 87.0% | −600,000−17.6% | Reduced | History |
| SANASana Biotechnology, Inc. | COM | 1,220,937 | $4.97M | 9.3% | −600,000−33.0% | Reduced | History |
| EGHT8X8 Inc | COM | 990,580 | $1.95M | 3.7% | 00.0% | Unchanged | History |